PT74703B - Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine - Google Patents

Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine

Info

Publication number
PT74703B
PT74703B PT74703A PT7470382A PT74703B PT 74703 B PT74703 B PT 74703B PT 74703 A PT74703 A PT 74703A PT 7470382 A PT7470382 A PT 7470382A PT 74703 B PT74703 B PT 74703B
Authority
PT
Portugal
Prior art keywords
naphtylmethyl
inyl
penetrable
hept
amongst
Prior art date
Application number
PT74703A
Other languages
English (en)
Portuguese (pt)
Other versions
PT74703A (en
Inventor
Jochen Ziegenmeyer
Joachim Franz
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT74703A publication Critical patent/PT74703A/pt
Publication of PT74703B publication Critical patent/PT74703B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT74703A 1981-04-06 1982-04-05 Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine PT74703B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (2)

Publication Number Publication Date
PT74703A PT74703A (en) 1982-05-01
PT74703B true PT74703B (en) 1984-05-30

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
PT74703A PT74703B (en) 1981-04-06 1982-04-05 Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine

Country Status (16)

Country Link
AU (1) AU564570B2 (enrdf_load_stackoverflow)
CA (1) CA1192496A (enrdf_load_stackoverflow)
DE (1) DE3212053A1 (enrdf_load_stackoverflow)
DK (1) DK155882A (enrdf_load_stackoverflow)
ES (1) ES511169A0 (enrdf_load_stackoverflow)
FI (1) FI821123L (enrdf_load_stackoverflow)
FR (1) FR2502951B1 (enrdf_load_stackoverflow)
GB (2) GB2098865B (enrdf_load_stackoverflow)
GR (1) GR75462B (enrdf_load_stackoverflow)
IL (1) IL65424A0 (enrdf_load_stackoverflow)
IT (1) IT8220611A0 (enrdf_load_stackoverflow)
MY (1) MY8600571A (enrdf_load_stackoverflow)
NL (1) NL8201413A (enrdf_load_stackoverflow)
NZ (1) NZ200232A (enrdf_load_stackoverflow)
PT (1) PT74703B (enrdf_load_stackoverflow)
SE (1) SE8202172L (enrdf_load_stackoverflow)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (enrdf_load_stackoverflow) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
WO1985003878A1 (en) * 1984-03-01 1985-09-12 Sandoz Ag Pharmaceutical compositions
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (en) * 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
EP0684832A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp MICROEMULSIONS CONTAINING PHARMACEUTICAL COMPOSITIONS.
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
EP1331002A3 (en) 1997-01-30 2004-01-14 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin A
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
IN188719B (enrdf_load_stackoverflow) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
BR9916063A (pt) * 1998-12-11 2002-01-22 Pharmasolutions Inc Composições auto-emulsificantes para medicamentos fracamente solúveis em água
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
NZ578735A (en) 2003-12-08 2011-06-30 Cpex Pharmaceuticals Inc Pharmaceutical compositions and methods for insulin treatment
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
JP2021531348A (ja) 2018-07-20 2021-11-18 リポシン，インク． 肝臓病

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (enrdf_load_stackoverflow) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
IT8220611A0 (it) 1982-04-06
ES8308698A1 (es) 1983-10-01
FI821123A0 (fi) 1982-03-31
ES511169A0 (es) 1983-10-01
GB2098865B (en) 1985-12-18
MY8600571A (en) 1986-12-31
GR75462B (enrdf_load_stackoverflow) 1984-07-20
GB2148711B (en) 1985-12-18
GB2098865A (en) 1982-12-01
NL8201413A (nl) 1982-11-01
FR2502951A1 (fr) 1982-10-08
GB2148711A (en) 1985-06-05
GB8408654D0 (en) 1984-05-16
AU8233482A (en) 1982-10-14
AU564570B2 (en) 1987-08-20
NZ200232A (en) 1985-08-16
FR2502951B1 (fr) 1985-12-06
PT74703A (en) 1982-05-01
IL65424A0 (en) 1982-07-30
SE8202172L (sv) 1982-10-07
FI821123A7 (fi) 1982-10-07
FI821123L (fi) 1982-10-07
DK155882A (da) 1982-12-10
CA1192496A (en) 1985-08-27
DE3212053A1 (de) 1982-10-21

Similar Documents

Publication Publication Date Title
PT74703B (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
HU188768B (en) Fungicides, insecticides and acaricides,as well as process for the preparation of their amino-pyrimidine derivatives active ingredients
DE3067390D1 (en) Sulfonyl ureas, processes for their preparation and pharmaceutical compositions containing these compounds
DE2961289D1 (en) Pyrimidones, processes for their preparation and pharmaceutical compositions containing them
DE2861289D1 (en) Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds
HUT53873A (en) Insecticides comprising nitro compounds as active ingredient and process for producing the active ingredients
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
DE3061586D1 (en) Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
DE2964819D1 (en) Platinum complexes, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments
DE2963061D1 (en) Hydantoin compounds, their preparation and pharmaceutical formulations containing them
IL59425A (en) Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation
DE3261497D1 (en) Substituted n-(4-indolyl-piperidino-alkyl) benzimidazolones, processes for their preparation and their use as pharmaceutical preparations
DE3266360D1 (en) Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation
DE3374012D1 (en) Platinum complexes, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
IL54468A0 (en) Process for the preparation of urea derivatives, urea derivatives obtained thereby and herbicide formulations comprising or containing said derivatives
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
IL59804A (en) Peptides having thymopoietin-like activity,their preparation and pharmaceutical compositions containing them
HUT44909A (en) Herbicides comprising 1-aryl-4-substituted-1,4-dihydro-5h-tetrazol-5-one derivatives and their sulphur analogs as active ingredient and process for producing the active ingredients and intermediaries thereof
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
ZA801846B (en) N,n-dimethyl-carbamic acid o-pyrazolyl esters,processes for their preparation and their use as agent for combating pests
ZA794623B (en) N,n-dimethyl-carbamic acid o-pyrimidinyl esters,processes for their preparation and their use as agents for combating pests
IL55427A (en) 2-hydrazonopropionic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same